GLP1R and type 2 diabetes mellitus: Glucagon-like-peptide 1 agonists (GLP1) are now widely recommended as both primary and add-on therapy for adults with type 2 diabetes, especially given their beneficial roles in weight reduction, as well as their cardiovascular and renal protective benefits [11].